Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification

Sarah Sharfstein Kawasaki, Janet S. Jacapraro, Darius A. Rastegar

Research output: Contribution to journalArticlepeer-review

Abstract

Benzodiazepine dependence is a common problem. However, there is limited data on safe and effective detoxification protocols for benzodiazepine-dependent patients. We reviewed the medical records of 310 patients treated with a 3-day fixed-dose phenobarbital taper for benzodiazepine dependence over a 5-year period between 2004 and 2009. We recorded the incidence of seizures, falls, delirium, and emergency department (ED) visits or readmission to our institution within 30 days as markers for safety; we also recorded how many patients had doses held because of sedation. The taper was well tolerated, although one quarter of the patients had at least one dose held because of sedation. There were no seizures, falls, or injuries reported. Six percent had a readmission, and 7% had an ED visit at our institution within 30 days of discharge, but only 3 patients required readmission for withdrawal symptoms. Overall, this protocol appears to be safe and effective.

Original languageEnglish (US)
Pages (from-to)331-334
Number of pages4
JournalJournal of Substance Abuse Treatment
Volume43
Issue number3
DOIs
StatePublished - Oct 1 2012

Keywords

  • Benzodiazepines
  • Detoxification
  • Phenobarbital

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification'. Together they form a unique fingerprint.

Cite this